A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells.

[1]  C. Zoccali,et al.  [Clinical trials (Part I)]. , 2010, Giornale Italiano di Nefrologia.

[2]  Donghoon Lee,et al.  In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. , 2008, Small.

[3]  U. Griesenbach.  Progress and Prospects: Gene Therapy Clinical Trials (Part 2) , 2007, Gene Therapy.

[4]  D. Schaffer,et al.  Library selection and directed evolution approaches to engineering targeted viral vectors , 2007, Biotechnology and bioengineering.

[5]  Jo Wixon,et al.  Gene therapy clinical trials worldwide to 2007—an update , 2007, The journal of gene medicine.

[6]  Nina M. Muñoz,et al.  Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. , 2007, Cancer research.

[7]  Shu Wang,et al.  Self-assembled ternary complexes of plasmid DNA, low molecular weight polyethylenimine and targeting peptide for nonviral gene delivery into neurons. , 2007, Biomaterials.

[8]  S. Wise.  Nanocarriers as an emerging platform for cancer therapy , 2007 .

[9]  A. C. Hunter.  Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. , 2006, Advanced drug delivery reviews.

[10]  Ruth Duncan,et al.  Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.

[11]  Leaf Huang,et al.  Gene therapy progress and prospects: non-viral gene therapy by systemic delivery , 2006, Gene Therapy.

[12]  U. Bakowsky,et al.  Trastuzumab-polyethylenimine-polyethylene glycol conjugates for targeting Her2-expressing tumors. , 2006, Bioconjugate chemistry.

[13]  Y. Katayama,et al.  The features and shortcomings for gene delivery of current non-viral carriers. , 2006, Current medicinal chemistry.

[14]  David Putnam,et al.  Polymers for gene delivery across length scales , 2006, Nature materials.

[15]  L. Young,et al.  Cancer gene-therapy: clinical trials. , 2006, Trends in biotechnology.

[16]  Helmut Ringsdorf,et al.  Polymer therapeutics—polymers as drugs, drug and protein conjugates and gene delivery systems: Past, present and future opportunities* , 2006, Journal of drug targeting.

[17]  H. Sontheimer,et al.  A role for ion channels in glioma cell invasion. , 2005, Neuron glia biology.

[18]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[19]  D. Largaespada,et al.  Nonviral vectors for cancer gene therapy: prospects for integrating vectors and combination therapies. , 2005, Current gene therapy.

[20]  Daniel W. Pack,et al.  Design and development of polymers for gene delivery , 2005, Nature Reviews Drug Discovery.

[21]  Donghoon Lee,et al.  Optical and MRI multifunctional nanoprobe for targeting gliomas. , 2005, Nano letters.

[22]  H. Lipps,et al.  Towards safe, non-viral therapeutic gene expression in humans , 2005, Nature Reviews Genetics.

[23]  Y. Barenholz,et al.  Polymers for DNA Delivery , 2005, Molecules.

[24]  N. Ueno,et al.  Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[25]  I. McNeish,et al.  Gene Therapy Progress and Prospects: cancer gene therapy using tumour suppressor genes , 2004, Gene Therapy.

[26]  V. L. Alvarez,et al.  Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice , 2004, Journal of Neuro-Oncology.

[27]  T. Kissel,et al.  Integrin targeting using RGD‐PEI conjugates for in vitro gene transfer , 2003, The journal of gene medicine.

[28]  B. Stewart,et al.  World Cancer Report , 2003 .

[29]  H. Sontheimer,et al.  Chlorotoxin, a scorpion‐derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin , 2002, Glia.

[30]  D. Fischer,et al.  Synthesis, Characterization, and Biocompatibility of Polyethylenimine-graft-poly(ethylene glycol) Block Copolymers , 2002 .

[31]  Ernst Wagner,et al.  Targeting tumors with non-viral gene delivery systems. , 2002, Drug discovery today.

[32]  S. W. Kim,et al.  Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[33]  A. Mikos,et al.  Poly(ethylenimine) and its role in gene delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[34]  J. Behr,et al.  In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. , 1997, Bioconjugate chemistry.

[35]  I. Verma,et al.  Gene therapy - promises, problems and prospects , 1997, Nature.

[36]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. Johnson.  Progress and Prospects , 1991 .